Oxford Immunotec partners with UK COVID-19 human challenge study
Oxford Immunotec partners with UK COVID-19 human challenge study 19th May 2021 UK diagnostic company Oxford Immunotec has collaborated with the UK COVID-19 human challenge study to analyse the T cell responses to SARS-CoV-2 infection in participants using its T-SPOT Discovery testing kit. The UK COVID-19 human challenge study, funded by the Department of Business, Energy and Industrial Strategy (BEIS) through the UK Vaccines Taskforce, is the first study of its type in the world. In March, the first stage of the trial launched to enable the identification of the most appropriate dose of the ...
Source: pharmatimes.com